Fundz

Nex Eos Diagnostics reported raising $5.1 Million in an initial SEC Form D filing, from an offering of $5.1 Million

PRIVATEFeb 15, 2023

Amount Raised

$5.1 Million

$5.1 Million sold, per SEC Form D (first sale Feb 14, 2023)

Round Type

Venture

PottstownHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as NexEos Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Starton Therapeutics raised $1.4M (Seed) on March 31, 2023.
  • Ablative Solutions raised $13M on March 31, 2023.
  • CCRC of Lee's Summit raised $11M on March 31, 2023.
  • iotaMotion raised $8.5M on March 30, 2023.
  • Readout raised $500K (Seed) on March 30, 2023.
  • Acta Pharmaceuticals raised $5M on March 29, 2023.

Who to call at NexEos Diagnostics, Inc., and when

A new round usually means NexEos Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NexEos Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NexEos Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NexEos Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NexEos Diagnostics, Inc.

Location

259 UMER STREET

Pottstown, Pennsylvania, United States

About

NexEos Bio is a privately held medical diagnostics and therapeutics company dedicated to improving the detection, diagnosis, treatment and life-long management of patients living with chronic, eosinophil-related inflammatory diseases. Our Mission is to transform the world’s foremost understanding of eosinophils in human biology into compassionate care solutions for patients through innovative diagnostic and treatment pathways.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NexEos Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDawn R., Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NexEos Diagnostics, Inc.'s next move

See what Strategic adds

NexEos Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.